Illegal Ayurvedic Medicines Unit Raided In Vasai By FDA, Medicines Seized

Palghar: A firm in Vasai in Palghar district was raided by the Food and Drug Administration and Ayurvedic medicines manufactured without licence and other items worth Rs 1 crore were seized, an official said on Friday.

The raid was carried out by the Intelligence Branch of FDA, Mumbai on a tip off on Thursday, he said.

“It held a manufacturing licence for Panchkula in Haryana but was carrying out manufacturing activities in its firm in Navghar in Vasai. Further investigation is under progress and suitable legal action would be taken against the said manufacturer after completion of investigation,” the official said.

Related Posts

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Ayurveda practitioner fined by ISM Council for violation of professional ethics

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

DoP may exempt 11 more drugs from public procurement rules

DoP may exempt 11 more drugs from public procurement rules

DoP calls for proposals to set up common facilities for medical device clusters

DoP calls for proposals to set up common facilities for medical device clusters